Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.
Michelle Marlborough
Advertisement
Chief product officer, AiCure, LLC
Articles by Michelle Marlborough
Advertisement
Latest Updated Articles
Why Machine Learning's Potential in Pharma Relies on Its TransparencyPublished: April 21st 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
From Evidence to Access: How Real-World Data Delivers for Patients
4
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
5